Developer docs
API playgroundTry for free, no card

Search company profiles

Narya Capital

Full company profile

uuid00007dw

Namestring
Narya Capital
Legal namestring
Narya
Websiteurl
naryavc.com
Company typeenum
Private
Founded yearint
2021
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersColumbus, United States
HQ citystring
Columbus
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
early-stage venture capital, deep tech investments, life sciences venture capital, seed-stage investing, technology venture capital
Industry1 code
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)
NAICS code1 code
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital
Social media profiles2 records
Revenue model1 record
1Venture Capital Fund Management
TypeLicensing Royalties
Description

Narya Capital generates returns through equity investments in early-stage companies across deep tech and life sciences sectors. The firm invests in portfolio companies and realizes returns through exits via IPOs, acquisitions, or secondary transactions.

stocktitan.net
Cost components2 values
Personnel, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Narya Capital is an early-stage venture capital firm that deploys capital into technology and science-driven startups, particularly in deep tech and life sciences. The firm invests equity across seed, Series A, and later rounds and realizes returns through exits such as IPOs, acquisitions, or secondary transactions. Portfolio companies span biotech, AI-powered platforms, defense technology, and healthcare navigation.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1Early-Stage Venture Capital Investments
CategoryVenture Capital
2Portfolio Company Strategic Support
CategoryVenture Capital
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Sector-focused venture capital firm specializing in deep tech, frontier science, and emerging-technology startups. Highly comparable to Narya given similar vertical specialization in capital-intensive, science-driven sectors and early-stage entry.

TypeDirect peer
Description

Venture capital firm investing in frontier technology, defense, biotech, and other deep-tech sectors. Repeated co-investor with Narya (Beren, Valinor, Peptilogics), making it a directly comparable peer in thesis and portfolio overlap.

TypeDirect peer
Description

Sector-focused venture capital firm with deep exposure to biotech, AI, and clean tech. Comparable to Narya through its vertical specialization in capital-intensive, science-driven early-stage companies.

TypeDirect peer
Description

Venture capital firm backing entrepreneurs in sectors including biotech, defense, logistics, and AI. Repeated co-investor with Narya (Chapter, Beren), with comparable thesis around capital-intensive, vertically specialized investments.

TypeBroad incumbent
Description

Large multi-stage venture capital firm with a deep-tech and healthcare practice. Co-investor with Narya in Valinor Enterprises; comparable at the portfolio company overlap level though operating at significantly larger fund size.

TypeBroad incumbent
Description

Large venture capital firm with dedicated bio/health and American Dynamism funds. While much larger and broader, a16z overlaps with Narya in thesis (biotech, AI, defense tech) and serves a comparable LP base seeking sector exposure.

TypeDirect peer
Description

Sector-focused venture capital firm backing deep tech, AI, and science-driven startups. Comparable to Narya in its early-stage, vertically specialized approach to frontier technology investments.

TypeDirect peer
Description

Venture capital firm investing in deep tech, computational biology, and advanced materials. Directly comparable to Narya in its focus on science-driven, capital-intensive early-stage companies.

TypeDirect peer
Description

Pre-seed and seed venture capital firm focused on deep tech, science, and engineering-driven startups. Comparable to Narya through its emphasis on early-stage, vertically specialized investments in technical founders.

TypeDirect peer
Description

Venture capital firm investing in purpose-driven founders across sectors including health, energy, and food tech. Comparable to Narya in its vertically focused, thesis-driven approach to early-stage investing.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment30 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Narya Capital

Venture Capitalnaryavc.com

Narya Capital firmographics

Firmographics
Name
Narya Capital
Legal name
Narya
Website
https://naryavc.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Narya Capital industry classification

Industry
Product category
Venture Capital
NAICS
Portfolio Management and Investment Advice (523940)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)

Keywords

  • Early-stage venture capital
  • Deep tech investments
  • Life sciences venture capital
  • Seed-stage investing
  • Technology venture capital

Where Narya Capital is headquartered

Location

Headquarters

HQ city
Columbus
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Narya Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations

Revenue model

  1. Venture Capital Fund Management: Narya Capital generates returns through equity investments in early-stage companies across deep tech and life sciences sectors. The firm invests in portfolio companies and realizes returns through exits via IPOs, acquisitions, or secondary transactions.

Narya Capital product offering

Product offering

Core offering

Narya Capital is an early-stage venture capital firm that deploys capital into technology and science-driven startups, particularly in deep tech and life sciences. The firm invests equity across seed, Series A, and later rounds and realizes returns through exits such as IPOs, acquisitions, or secondary transactions. Portfolio companies span biotech, AI-powered platforms, defense technology, and healthcare navigation.

Differentiator

Problem solved

Functional benefit

Products and services

  • Early-Stage Venture Capital Investments
  • Portfolio Company Strategic Support

Companies that use Narya Capital

Customer profile

Segments1 record

Ideal customer profiles1 record

Narya Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Narya Capital partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Narya Capital competitors and assessment

Company assessment

Direct peers

  • Lux Capital: Sector-focused venture capital firm specializing in deep tech, frontier science, and emerging-technology startups. Highly comparable to Narya given similar vertical specialization in capital-intensive, science-driven sectors and early-stage entry.
  • Founders Fund: Venture capital firm investing in frontier technology, defense, biotech, and other deep-tech sectors. Repeated co-investor with Narya (Beren, Valinor, Peptilogics), making it a directly comparable peer in thesis and portfolio overlap.
  • Khosla Ventures: Sector-focused venture capital firm with deep exposure to biotech, AI, and clean tech. Comparable to Narya through its vertical specialization in capital-intensive, science-driven early-stage companies.
  • 8VC: Venture capital firm backing entrepreneurs in sectors including biotech, defense, logistics, and AI. Repeated co-investor with Narya (Chapter, Beren), with comparable thesis around capital-intensive, vertically specialized investments.
  • Innovation Endeavors: Sector-focused venture capital firm backing deep tech, AI, and science-driven startups. Comparable to Narya in its early-stage, vertically specialized approach to frontier technology investments.
  • DCVC: Venture capital firm investing in deep tech, computational biology, and advanced materials. Directly comparable to Narya in its focus on science-driven, capital-intensive early-stage companies.
  • SciFi VC: Pre-seed and seed venture capital firm focused on deep tech, science, and engineering-driven startups. Comparable to Narya through its emphasis on early-stage, vertically specialized investments in technical founders.
  • Obvious Ventures: Venture capital firm investing in purpose-driven founders across sectors including health, energy, and food tech. Comparable to Narya in its vertically focused, thesis-driven approach to early-stage investing.

Broad incumbents

  • General Catalyst: Large multi-stage venture capital firm with a deep-tech and healthcare practice. Co-investor with Narya in Valinor Enterprises; comparable at the portfolio company overlap level though operating at significantly larger fund size.
  • Andreessen Horowitz: Large venture capital firm with dedicated bio/health and American Dynamism funds. While much larger and broader, a16z overlaps with Narya in thesis (biotech, AI, defense tech) and serves a comparable LP base seeking sector exposure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Narya Capital social profiles

Digital presence

Narya Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Narya Capital leadership team

Management profile

Number of profiles

Profiles3 records

Narya Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Narya Capital M&A and investment

M&A and investment

M&A

Investments30 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Narya Capital

What does Narya Capital do?

Narya Capital is an early-stage venture capital firm that deploys capital into technology and science-driven startups, particularly in deep tech and life sciences. The firm invests equity across seed, Series A, and later rounds and realizes returns through exits such as IPOs, acquisitions, or secondary transactions. Portfolio companies span biotech, AI-powered platforms, defense technology, and healthcare navigation.

Is Narya Capital a public or private company?

Narya Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Narya Capital founded?

Narya Capital was founded in 2021. It employs 1 to 10 people.

Where is Narya Capital based?

Narya Capital is headquartered in Columbus, United States, in the North America region.

How does Narya Capital make money?

One revenue line is on record: venture Capital Fund Management.

Who are Narya Capital's main competitors?

Direct peers on record are Lux Capital, Founders Fund, Khosla Ventures, 8VC, Innovation Endeavors, DCVC, SciFi VC and Obvious Ventures. Broad incumbents are General Catalyst and Andreessen Horowitz.

Does Narya Capital have an API?

No public API is recorded for Narya Capital.

What industry is Narya Capital in?

Narya Capital's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Model AnalystHe Built Big Law’s $10 Billion Firm. Now He’s Betting Against ItDavid Fox, the dealmaker credited with building Kirkland & Ellis into a $10.56 billion firm, has co-founded Irving Technology and launched Irving, an AI-powered law firm employing fewer than 10 people in New York that has already advised on small deals in stealth mode. The venture's key innovation is a management services organization structure that separates the lawyer-owned law firm from an investor-owned technology company, allowing outside capital for the first time in the industry while technically complying with ABA Model Rule 5.4. Fox has raised undisclosed funding from Narya Capital, Addition, Jeff Hammes, and his own Antiportfolio Ventures, positioning to compete against established AI legal startups like Harvey and Norm Law (backed by Bain Capital and Blackstone) while incumbents like Kirkland ($500 million AI budget) and Cleary Gottlieb build in-house capabilities.FinSMEsBeren Therapeutics Raises $300M in Combined Equity and Debt FinancingBeren Therapeutics raised $300M in a combined equity and debt financing round, with $135M equity and $165M non-dilutive credit. The funds will accelerate commercial readiness for its lead asset, expand diagnostic networks, and build a patient access program. The company's lead asset has an FDA PDUFA action date of November 17, 2026.FinSMEsReprogram Biosciences Closes Seed FundingReprogram Biosciences raised an undisclosed seed amount, bringing total funding to $6M. Backers include Unshackled Ventures, 1517 Fund, and Narya. The company will use the funds for its lead program, AI discovery engine, and CMC activities.VC News DailyReprogram Biosciences Closes $6M Seed FinancingReprogram Biosciences closed its seed financing, bringing total capital raised to $6 million since its founding in 2025. Investors include Unshackled Ventures, 1517 Fund, and Narya. The company develops mRNA-based therapeutics for solid tumors.WowtaleTrue Anomaly, which is building a space interception system, has secured an investment of 650 million dollars.True Anomaly raised $650 million in a Series D round led by Eclipse and Riot Ventures, valuing the space defense startup at $2.2 billion. The company, which developed autonomous orbital vehicles and software, is one of 12 prime contractors selected for the U.S. Space Force's Golden Dome program. It plans to execute about 12 missions within 18 months.Washington TechnologyTrue Anomaly fetches $650M in Series D roundTrue Anomaly raised $650 million in a Series D round led by Eclipse and Riot Ventures. The capital will support hiring to 500 employees and manufacturing capacity for a dozen missions over 18 months, including a Space Force VICTUS HAZE mission.FinSMEsTrue Anomaly Raises $650M in Series D FundingTrue Anomaly raised $650M in Series D funding led by Eclipse and Riot Ventures, with participation from Paradigm, Atreides, and others. The round included $50M in debt from Stifel Bank, bringing total capital to $1B since 2022. Funds will accelerate delivery of autonomous spacecraft, payloads, and interceptors, with missions planned in 18 months.The SaaS NewsChapter Raises $100 Million Series EChapter, a New York-based AI retirement company, raised $100 million in Series E funding led by Generation Investment Management. The capital will accelerate growth and expand its product suite beyond Medicare into broader retirement and financial decision-making services.MedCity NewsWith $100M Raise, Chapter Targets Medicare Mismatches for SeniorsChapter, a Medicare navigation platform, raised $100 million in Series E funding led by Generation Investment Management. The New York-based company's valuation reached $3 billion, and it claims seniors face $100 billion in deadweight loss annually from coverage mismatches. The company plans to expand beyond Medicare with new products.FinSMEsChapter Raises $100M in Series E FundingChapter, a Medicare navigation platform, raised $100M in Series E funding led by Generation Investment Management. The company grew revenue 3x in 2025 and surpassed $100M ARR, and will use the funds to accelerate growth and launch additional financial products.